Arrowhead Pharmaceuticals, Inc. (ARWR) Price Prediction & ForecastARWRArrowhead Pharmaceuticals, Inc.

Alphio's ARWR stock price prediction model matches the current Arrowhead Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $56.65 (+1.34%). The 1-week path is $53.52 (-4.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Arrowhead Pharmaceuticals Inc is currently a hold. The stock is priced at $55.90, significantly below the analyst price targets of $74 from Goldman Sachs and $108 from Citi, indicating potential upside. However, the RSI is at a very low 17.125, suggesting the stock is oversold, which could lead to a rebound. The company has shown promising early trial results for its Alzheimer's drug, ARO-MAPT, with a 73% reduction in tau protein levels, which could drive future growth. However, the risk remains high as the stock has a forward P/E of 111.11 and has seen a 10.92% decline over the past five days, indicating volatility and uncertainty in the market.

Arrowhead Pharmaceuticals, Inc. (ARWR) last closed at $55.9, losing -4.44%. These facts feed the 1-day and 1-week ARWR price prediction above.